- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02615665
Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases
November 24, 2015 updated by: Prof. Guido Torzilli, University of Milan
Role of CD3+ and NKp46+ Cells in Resected Colorectal Liver Metastases.
The long-term outcome of patients resected for colorectal liver metastases (CLM) after neoadjuvant chemotherapy (CHT) depends by several tumoral and non-tumoral factors, such as the immune response to the tumor and to the CHT.
The aim of this study was to investigate the impact of the pathological and immunological response in patients undergoing liver resection for CLM after CHT in regards to the long-term outcome.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The immunoreactivity to CD3+ and NKp46+ cells inside the tumor, at the border between the tumor and the normal liver, and inside the normal liver will be tested by computer-assisted image analyses in patients undergoing liver resection for CLM between 2005 and 2013 preoperatively treated with oxaliplatin or irinotecan with or without bevacizumab or cetuximab.
The survival will be assessed in relation to several prognostic factors and to that immunoreactivity.
Study Type
Observational
Enrollment (Actual)
121
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Milan
-
Rozzano, Milan, Italy, 20089
- Department of Hepatobiliary and General Surgery, Humanitas Research Hospital, University of Milan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with colorectal liver metastases scheduled for surgery at our Unit.
Description
Inclusion Criteria:
- histological proven colorectal liver metastases
- complete clinical, surgical, pathological and follow-up data
Exclusion Criteria:
- non-radical surgery
- incomplete clinical, surgical, pathological and follow-up data
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Overall survival
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Guido Torzilli, MD, PhD, Humanitas University, Humanitas Research Hospital IRCCS
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hudspeth K, Donadon M, Cimino M, Pontarini E, Tentorio P, Preti M, Hong M, Bertoletti A, Bicciato S, Invernizzi P, Lugli E, Torzilli G, Gershwin ME, Mavilio D. Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. J Autoimmun. 2016 Jan;66:40-50. doi: 10.1016/j.jaut.2015.08.011. Epub 2015 Aug 30.
- Hudspeth K, Pontarini E, Tentorio P, Cimino M, Donadon M, Torzilli G, Lugli E, Della Bella S, Gershwin ME, Mavilio D. The role of natural killer cells in autoimmune liver disease: a comprehensive review. J Autoimmun. 2013 Oct;46:55-65. doi: 10.1016/j.jaut.2013.07.003. Epub 2013 Jul 21.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (Actual)
August 1, 2015
Study Completion (Actual)
August 1, 2015
Study Registration Dates
First Submitted
November 18, 2015
First Submitted That Met QC Criteria
November 24, 2015
First Posted (Estimate)
November 26, 2015
Study Record Updates
Last Update Posted (Estimate)
November 26, 2015
Last Update Submitted That Met QC Criteria
November 24, 2015
Last Verified
November 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NKTCellsInCLM
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Liver Metastases
-
Humanitas Clinical and Research CenterCompletedColorectal Cancer | Liver Metastases | Immunotherapy | Colorectal Liver Metastases
-
Mayo ClinicRecruitingColorectal Cancer | Colorectal Liver MetastasesUnited States
-
Shanghai Changzheng HospitalNot yet recruiting
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Completed
-
Fudan UniversityNot yet recruitingColorectal Cancer Liver MetastasesChina
-
Vastra Gotaland RegionRecruitingColorectal Cancer | Liver Metastases | Colorectal Liver MetastasesSweden
-
Fudan UniversityUnknown
-
Sun Yat-sen UniversityRecruitingColorectal Cancer Liver Metastases | RegorafenibChina
-
Ye XuUnknownResected Liver Metastases From Colorectal CancerChina
-
University of ZurichCompletedColorectal Liver MetastasesSwitzerland, France, Spain
Clinical Trials on Hepatic resection
-
University of Milano BicoccaHumanitas Clinical and Research Center; Niguarda Hospital; Azienda Ospedaliero... and other collaboratorsRecruitingHepatocellular Carcinoma | Circulating Tumor Cell | Recurrent Hepatocellular CarcinomaItaly
-
University of Maryland, BaltimoreRecruiting
-
University of MilanCompletedHepatectomy | Bile Leak | Hepatic Resection | Biliary Fistula | Liver ResectionItaly
-
National Taiwan University HospitalNational Science Council, TaiwanUnknown
-
Humanitas Clinical and Research CenterCompletedHepatocellular Carcinoma
-
University of MilanCompletedHepatocellular Carcinoma | Cirrhosis | Multiple TumorsItaly
-
University of MilanCompletedHepatectomy | Surgery | Liver Tumors | Liver Resection
-
National Taiwan University HospitalUnknownColorectal CancerTaiwan
-
University of MilanUniversity of BolognaCompletedMultiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases.Colon Cancer | Colorectal Liver Metastases
-
Guangxi Medical UniversityUnknown